The Government of India’s expanded Production-Linked Incentive (PLI) 2.0 scheme is redefining the landscape for manufacturing in sectors such as electronics and pharmaceuticals. By linking financial incentives directly to incremental output and value addition, the policy is driving global supply-chain shifts toward India. T&A Consulting supports investors and manufacturers in navigating the PLI framework, identifying eligible product lines, and establishing compliant operations that capture long-term incentives and market advantages.
The Complexity of Cross-Border Expansion
While PLI 2.0 presents a major opportunity, tapping into it demands clarity on evolving regulations, approval criteria, and infrastructure readiness. Manufacturers must interpret policy notifications, state-level coordination, and procurement localization norms correctly to avoid compliance gaps.
- Multiple ministries manage sector-specific PLI schemes, making documentation and reporting requirements intricate.
- Eligibility depends on production thresholds, local value-addition, and investment milestones that vary by sector.
- Rapid technology shifts in electronics and pharma require adaptive investment strategies and continuous product innovation.
- Global competition for the same supply-chain segments intensifies pressure to establish operations swiftly and efficiently.
In such a high-potential yet complex environment, foreign and domestic manufacturers benefit from an advisory partner like T&A Consulting — combining regulatory clarity, sector insight, and on-ground execution to ensure successful participation in PLI-driven growth.
How T&A Consulting Helps — From Insight to Implementation
T&A Consulting’s advisory approach integrates policy interpretation with practical business execution, ensuring clients maximize incentive benefits while maintaining operational compliance.
- Market Intelligence & Opportunity Validation
T&A maps high-potential sub-sectors in electronics (semiconductors, mobile devices, components) and pharma (bulk drugs, formulations, medical devices), supported by data on demand trends, import substitution potential, and incentive alignment. - Feasibility & Risk Diagnosis
Comprehensive technical, financial, and ESG assessments help clients estimate returns, compliance costs, and long-term scalability under PLI frameworks. - Partner & Channel Search
The firm identifies reliable manufacturing partners, technology collaborators, and suppliers across India’s electronics clusters and pharma parks. - Incorporation, Legal & Compliance Setup
T&A assists in company registration, industrial licensing, customs and GST setup, and filing of PLI eligibility documents with relevant ministries. - Deal Structuring & ESG Integration
Advisory covers incentive documentation, investment structuring, and embedding sustainability metrics such as waste management and clean-energy adoption. - In-Market Representation & Execution Support
Continuous support includes progress reporting to ministries, liaising with state authorities, and monitoring production milestones to ensure incentive continuity.
With us, “strategy” doesn’t stop at the slide deck. We help you do — bridging the last mile from plan to reality.
Special Focus
PLI 2.0 extends across 14 sectors, but its deepest impact is visible in electronics and pharmaceuticals — both critical to India’s self-reliance and export competitiveness.
- Electronics Manufacturing: India aims to achieve over USD 300 billion in electronics production by FY26. The PLI 2.0 for IT hardware and semiconductors offers graded incentives to attract global majors for local assembly and component manufacturing.
- Pharmaceuticals and APIs: The PLI for bulk drugs and key starting materials incentivizes backward integration, reducing import dependency and strengthening domestic R&D capacity.
- Medical Devices: Enhanced support for device clusters encourages innovation and cost-effective production, especially in diagnostics and imaging equipment.
- Job Creation and Skill Development: The multiplier effect of PLI 2.0 is expected to create more than one million skilled jobs while expanding ancillary industries and logistics networks.
How T&A Adds Distinct Value over Standalone Advisory
- Full-lifecycle alignment: T&A partners with clients from policy interpretation and incentive filing to plant commissioning and operational scaling.
- In-market presence & network: Strong connections with central ministries, state agencies, and industry councils accelerate approvals and reduce delays.
- Cross-domain experience: The firm’s expertise across electronics, pharma, and allied infrastructure ensures integrated, end-to-end solutions.
- Outcome accountability: Deliverables are tied to measurable milestones — incentive disbursement, capacity creation, and export growth.
- Mitigated downside: Through local verification, ESG safeguards, and compliance monitoring, T&A reduces operational and reputational risks.
Looking Ahead
- Electronics deep-localization: India’s growing semiconductor and component ecosystems will strengthen global supply-chain resilience.
- Pharma innovation push: PLI incentives will shift focus from volume-based manufacturing to value-driven innovation and biosimilars.
- Convergence of tech and policy: Integration of digital monitoring and blockchain in PLI reporting will enhance transparency.
- Global investment confidence: Simplified compliance, infrastructure upgrades, and export-linked benefits will make India a long-term manufacturing hub.
Thinking of expanding manufacturing operations or leveraging India’s PLI incentives? T&A Consulting can guide you through every step — from opportunity mapping to operational success. Contact us at: pnijhawan@taglobalgroup.com to explore how we can collaborate on market entry, incentive optimization, and manufacturing growth strategies.
Sources & references:
ElectronicsB2B,
Pharmabiz,
LiveMint,
Business Today,
NITI Aayog
